The Academy for the Advancement of Aesthetics: Botulinum Toxin Type A
 
Release Date: 2/3/2017
Last Reviewed: 12/17/2016
Expiration Date: 2/3/2019
Time to Complete Activity: 3.0 hours

Steering Committee
Sabrina G. Fabi, MD, FAAD, FAACS
Volunteer Assistant Clinical Professor
Department of Medicine/Dermatology
University of California, San Diego
Goldman Butterwick Fitzpatrick Groff and Fabi Cosmetic Laser Dermatology
San Diego, CA
 
Tatjana Pavicic, MD
Munich, Germany
 
Kyle K. Seo, MD
Director
Modelo Clinic
Gangham-gu, Seoul, South Korea
Clinical Professor
Seoul National University Hospital
Jongno-gu, Seoul, South Korea
 
This activity is provided by Paradigm Medical Communications, LLC. 
 
Target Audience
This activity has been designed to address the educational needs of dermatologists; plastic surgeons; facial plastic surgeons; ocular plastic surgeons; ophthalmologists; medical professionals from the following disciplines: dermatology, plastic surgery, otolaryngology, ophthalmology, dermatologic surgery, cosmetic surgery, facial plastic surgery, and ocular plastic surgery. It may also be of benefit to nurses in the field of aesthetic medicine and other healthcare providers (HCPs) who are involved in aesthetic medicine. 
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Describe the mechanism of action of botulinum toxin type A (BoNT/A) in facial aesthetic medicine
  • Differentiate BoNT/As for facial aesthetic medicine based on indications, efficacy, and safety
  • Review basic dosing strategies for injecting the most common treatment areas with each of the BoNT/A products
  • Identify the possible adverse events associated with BoNTs and how to manage them
 
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
EACCME Accreditation Statement
“The Academy for the Advancement of Aesthetics: Botulinum Toxin Type A”, made available on http://aestheticcare.org and organized by Siyemi Learning and Paradigm Medical Communications is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

This activity is provided by Paradigm Medical Communications, LLC and Siyemi Learning.  

EACCME Credit Designation Statement
“The Academy for the Advancement of Aesthetics: Botulinum Toxin Type A, made available on http://aestheticcare.org and organized by Siyemi Learning and Paradigm Medical Communications, is awarded 3 European CME credits (ECMECs).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS- EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
 
PA Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 3.0 Category 1 credits for completing this activity.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.  Individuals are responsible for checking with the AANPCP for further guidelines.
 
Disclosure of Commercial Support
This activity is supported by an educational grant from Merz Pharmaceuticals GmbH.
 
Instructions for Participation
To receive a CME certificate of participation, participants must:
  • Follow instructions to register or log in with your professional information and complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
     
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding ACCME credit, contact the Paradigm CME Department at (845) 398-5949.

For questions regarding EACCME credit, contact Siyemi Learning at +44 161 306 8518 or CME@siyemi.org. 
 
There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 audio/video.
 
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues, please email us at contactus@paradigmmc.com.
 
Disclosures
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Steering Committee
Sabrina G. Fabi, MD, FAAD, FAACS
Grants/research support: Kythera Biopharmaceuticals, Inc; Revance Therapeutics, Inc; Ulthera, Inc
Honoraria or consultation fees: Allergan, Inc; Biopelle, Inc; Galderma Laboratories; Lumenis; Merz North America, Inc; Zeltiq Aesthetics, Inc
Speaker’s Bureau: Allergan, Inc; Biopelle, Inc; Galderma Laboratories; Lumenis; Merz North America, Inc; Zeltiq Aesthetics, Inc
 
Tatjana Pavicic, MD
Grants/research support: Ispen; Merz Pharmaceuticals
Honoraria or consultation fees: Beiersdorf Inc; Cynosure, Inc; Galderma S.A.; Lutronic; Merz Pharmaceuticals
 
Kyle K. Seo, MD
Grants/research support: Daewoong Pharmaceutical Co., Ltd; L G Life Sciences, Ltd
Honoraria or consultation fees: Merz
 
Paradigm Medical Communications, LLC and Siyemi Learning staff members have no financial relationships to disclose.
 
Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, independent, fairly balanced, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. In this activity, the trade names for aesthetic products are used for clarity. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.